Form 8-K · Current report
Exelon 8-K, filed Oct 30, 2026
- Filed
- CIK
- 0001109357
- Accession no.
- 0001109357-26-000092
Summary
Exelon Corporation reported its third-quarter 2026 financial results, achieving adjusted (non-GAAP) operating earnings of $0.87 per share, while narrowing its full-year guidance and noting improved national utility reliability rankings. Exelon completed its 2026 planned debt financings to support ongoing investments across its utility operations.
Key points
- The company reported adjusted (non-GAAP) operating earnings of $0.87 per share for the third quarter of 2026.
- Exelon narrowed its full-year 2026 adjusted operating earnings guidance to $2.85 to $2.91 per share and affirmed continued earnings growth near the top end of 5-7% from 2025 to 2029.
- Exelon's utilities ranked 1st, 2nd, 5th, and 6th in the nation for reliability.
- Regulatory progress included final orders in the Pepco Maryland base rate case and Maryland Lessons Learned.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. Item 7.01. Regulation FD Disclosure. On October 30, 2026, Exelon Corporation (Exelon) announced via press release its results for the third quarter ended September 30, 2026. A copy of the press release and related attachments are attached hereto as Exhibit 99.1. Also attached as Exhibit 99.2 to this Current Report on Form 8-K are the presentation slides to be used at the third quarter 2026 earnings conference call. This Form 8-K and the attached exhibits are provided under Items 2.02, 7.01 and 9.01 of Form 8-K and are furnished to, but not filed with, the Securities and Exchange Commission (SEC). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.